Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Pfizer
Hoffmann-La Roche
Pfizer
Takeda
Shasqi, Inc.
Tempus AI
Elevation Oncology
Inhibrx Biosciences, Inc
NantCell, Inc.
Turning Point Therapeutics, Inc.
Washington University School of Medicine
NKGen Biotech, Inc.
Yale University
Fusion Pharmaceuticals Inc.
Fate Therapeutics
Montefiore Medical Center
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
University of Wisconsin, Madison
CureOne
Institut Cancerologie de l'Ouest
University of Pittsburgh
Masonic Cancer Center, University of Minnesota
Papworth Hospital NHS Foundation Trust
Stanford University
Yale University
Calando Pharmaceuticals
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
University of Wisconsin, Madison